Shuichi Hironaka

Shuichi Hironaka

UNVERIFIED PROFILE

Are you Shuichi Hironaka?   Register this Author

Register author
Shuichi Hironaka

Shuichi Hironaka

Publications by authors named "Shuichi Hironaka"

Are you Shuichi Hironaka?   Register this Author

72Publications

1430Reads

10Profile Views

Anti-angiogenic therapies for gastric cancer.

Authors:
Shuichi Hironaka

Asia Pac J Clin Oncol 2019 Aug 20;15(4):208-217. Epub 2019 May 20.

Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.13174DOI Listing
August 2019

Edoxaban for Cancer-Associated Venous Thromboembolism.

Authors:
Shuichi Hironaka

N Engl J Med 2018 07;379(1):93-4

Oita University, Yufu, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1806646DOI Listing
July 2018

[Advances in secondary chemotherapy for gastric cancer].

Gan To Kagaku Ryoho 2015 Apr;42(4):398-402

Dept. of Clinical Trial Promotion, Chiba Cancer Center.

View Article

Download full-text PDF

Source
April 2015

Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial.

J Clin Oncol 2013 Dec 4;31(35):4438-44. Epub 2013 Nov 4.

Shuichi Hironaka, Chiba Cancer Center, Chiba; Shinya Ueda and Isamu Okamoto, Kinki University, Osakasayama; Hirofumi Yasui, Shizuoka Cancer Center, Shizuoka; Tomohiro Nishina, National Hospital Organization Shikoku Cancer Center, Matsuyama; Masahiro Tsuda, Hyogo Cancer Center, Akashi; Takehiko Tsumura, Osaka Red Cross Hospital; Naotoshi Sugimoto, Osaka Medical Center for Cancer and Cardiovascular Diseases; Shinya Tokunaga, Osaka City General Hospital; Kazumasa Fujitani, Osaka National Hospital, Osaka; Hideki Shimodaira, Tohoku University Hospital, Sendai; Toshikazu Moriwaki and Ichinosuke Hyodo, University of Tsukuba, Tsukuba; Taito Esaki, National Kyushu Organization Kyushu Cancer Center, Fukuoka; Michitaka Nagase, Jichi Medical University, Shimono; Kensei Yamaguchi, Saitama Cancer Center, Saitama; Takashi Ura, Aichi Cancer Center Hospital, Nagoya; Yasuo Hamamoto, Tochigi Cancer Center, Utsunomiya; Satoshi Morita, Yokohama City University Graduate School of Medicine, Yokohama; and Narikazu Boku, St Marianna University School of Medicine, Kawasaki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5805DOI Listing
December 2013

Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.

Jpn J Clin Oncol 2013 Jun 12;43(6):608-15. Epub 2013 Apr 12.

Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt048DOI Listing
June 2013

Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation study.

Jpn J Clin Oncol 2012 Apr 27;42(4):278-86. Epub 2012 Feb 27.

Breast Cancer Division, Department of Medical Oncology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hys012DOI Listing
April 2012

[Multicenter clinical trial for esophageal cancer in foreign countries].

Authors:
Shuichi Hironaka

Nihon Rinsho 2011 Aug;69 Suppl 6:464-8

Clinical Trial Promotion Department, Chiba Cancer Center.

View Article

Download full-text PDF

Source
August 2011

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy.

Cancer Chemother Pharmacol 2011 Jun 12;67(6):1265-72. Epub 2010 Aug 12.

Gastrointestinal Oncology Division, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1422-xDOI Listing
June 2011

Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.

Jpn J Clin Oncol 2010 Nov 5;40(11):1014-20. Epub 2010 Jul 5.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq104DOI Listing
November 2010

S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.

Jpn J Clin Oncol 2010 Jun 26;40(6):567-72. Epub 2010 Feb 26.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq005DOI Listing
June 2010

Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination.

Gastric Cancer 2009 5;12(3):153-7. Epub 2009 Nov 5.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Shizuoka, 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-009-0517-8DOI Listing
January 2010

Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.

Jpn J Clin Oncol 2008 Dec 6;38(12):810-5. Epub 2008 Nov 6.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Sunto-Gun, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyn109DOI Listing
December 2008

The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancer.

Jpn J Clin Oncol 2007 Feb 1;37(2):96-101. Epub 2007 Feb 1.

Division of Gastrointestinal Oncology and Endoscopy, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyl145DOI Listing
February 2007

Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer.

Gastric Cancer 2006 ;9(3):203-7

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-006-0379-2DOI Listing
January 2007

Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer.

Gastric Cancer 2006 ;9(1):14-8

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Shizuoka, 411-8777, Japan.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/27/4C/2667.full.pdf
Web Search
http://link.springer.com/10.1007/s10120-005-0351-6
Publisher Site
http://dx.doi.org/10.1007/s10120-005-0351-6DOI Listing
June 2006

Computer-assisted analysis of biopsy specimen microvessels predicts the outcome of esophageal cancers treated with chemoradiotherapy.

Clin Cancer Res 2006 Mar;12(6):1735-42

Pathology Division, Center for Innovative Oncology, National Cancer Center at Kashiwa, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1982DOI Listing
March 2006

Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.

Int J Clin Oncol 2005 Dec;10(6):429-32

Division of Gastrointestinal Oncology and Endoscopy, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-005-0502-0DOI Listing
December 2005

Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.

Jpn J Clin Oncol 2005 Jun 16;35(6):316-23. Epub 2005 Jun 16.

Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyi095DOI Listing
June 2005

Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.

J Clin Oncol 2003 Jul;21(14):2697-702

Radiation Oncology Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.03.055DOI Listing
July 2003

Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.

Gastrointest Endosc 2002 Oct;56(4):517-21

Division of Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mge.2002.128104DOI Listing
October 2002

Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy.

Clin Cancer Res 2002 Jan;8(1):124-30

Pathology Division, National Cancer Center Research Institute East, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
January 2002

Five-year survivor with liver metastasis from gastric cancer successfully treated with systemic chemotherapy.

Gastric Cancer 2000 Sep;3(2):106-109

Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Chiba 277-8557, Japan.

View Article

Download full-text PDF

Source
September 2000